J Clin Oncol 29 (2): 149-56, 2011.[PUBMED Abstract] Baselga J, Cort√©s J, Kim SB, et al.: Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.
N Engl J Med 366 (2): 109-19, 2012.[PUBMED Abstract] Swain SM, Baselga J, Kim SB, et al.: Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer.
N Engl J Med 372 (8): 724-34, 2015.[PUBMED Abstract] Swain SM, Miles D, Kim SB, et al.: Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study.